369 related articles for article (PubMed ID: 11108147)
61. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
62. The role of nuclear factor-kappaB in the effect of angiotensin II in the paraventricular nucleus in protecting the gastric mucosa from ischemia-reperfusion injury in rats.
Zhang YM; Wei EQ; Hu X; Qiao WL; Shi Y; Xu M; Zhang JF
J Gastroenterol; 2008; 43(9):687-98. PubMed ID: 18807130
[TBL] [Abstract][Full Text] [Related]
63. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
[TBL] [Abstract][Full Text] [Related]
64. NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2.
Wei C; Li L; Gupta S
Mol Cell Biochem; 2014 Feb; 387(1-2):135-41. PubMed ID: 24178239
[TBL] [Abstract][Full Text] [Related]
65. Are transcription factors NF-kappaB and AP-1 involved in the ANG II-stimulated production of proinflammatory cytokines induced by LPS in dehydrated rats?
Sasaki K; Taniguchi M; Miyoshi M; Goto O; Sato K; Watanabe T
Am J Physiol Regul Integr Comp Physiol; 2005 Dec; 289(6):R1599-608. PubMed ID: 16051721
[TBL] [Abstract][Full Text] [Related]
66. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.
Golovchenko I; Goalstone ML; Watson P; Brownlee M; Draznin B
Circ Res; 2000 Oct; 87(9):746-52. PubMed ID: 11055977
[TBL] [Abstract][Full Text] [Related]
67. Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.
Ma E; Wu C; Chen J; Wo D; Ren DN; Yan H; Peng L; Zhu W
Biomed Pharmacother; 2023 Sep; 165():115275. PubMed ID: 37541173
[TBL] [Abstract][Full Text] [Related]
68. Mechanisms for inducible control of angiotensinogen gene transcription.
Brasier AR; Li J
Hypertension; 1996 Mar; 27(3 Pt 2):465-75. PubMed ID: 8613188
[TBL] [Abstract][Full Text] [Related]
69. Angiotensin II induces the exocytosis of galectin-3 via integrin αv/AKT/NF-κB signaling pathway.
Tian L; Coletti D; Li ZL
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5949-5957. PubMed ID: 31298346
[TBL] [Abstract][Full Text] [Related]
70. Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts.
Cowling RT; Zhang X; Reese VC; Iwata M; Gurantz D; Dillmann WH; Greenberg BH
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1176-83. PubMed ID: 15879490
[TBL] [Abstract][Full Text] [Related]
71. l-Carnitine ameliorates the oxidative stress response to angiotensin II by modulating NADPH oxidase through a reduction in protein kinase c activity and NF-κB translocation to the nucleus.
Blanca AJ; Ruiz-Armenta MV; Zambrano S; Miguel-Carrasco JL; González-Roncero FM; Fortuño A; Revilla E; Mate A; Vázquez CM
Food Chem; 2017 Aug; 228():356-366. PubMed ID: 28317735
[TBL] [Abstract][Full Text] [Related]
72. The NF-kappaB family of transcription factors and its regulation.
Oeckinghaus A; Ghosh S
Cold Spring Harb Perspect Biol; 2009 Oct; 1(4):a000034. PubMed ID: 20066092
[TBL] [Abstract][Full Text] [Related]
73. Phosphocreatine attenuates angiotensin II-induced cardiac fibrosis in rat cardiomyocytes through modulation of MAPK and NF-κB pathway.
Fei AH; Wang FC; Wu ZB; Pan SM
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2726-33. PubMed ID: 27383329
[TBL] [Abstract][Full Text] [Related]
74. Identification of novel pretranslational regulatory mechanisms for NF-κB activation.
Huang X; Gong R; Li X; Virtue A; Yang F; Yang IH; Tran AH; Yang XF; Wang H
J Biol Chem; 2013 May; 288(22):15628-40. PubMed ID: 23515310
[TBL] [Abstract][Full Text] [Related]
75. Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition.
Dechend R; Fiebler A; Lindschau C; Bischoff H; Müller D; Park JK; Dietz R; Haller H; Luft FC
Am J Hypertens; 2001 Jun; 14(6 Pt 2):55S-61S. PubMed ID: 11411766
[TBL] [Abstract][Full Text] [Related]
76. Significance of the transcription factor KLF5 in cardiovascular remodeling.
Nagai R; Suzuki T; Aizawa K; Shindo T; Manabe I
J Thromb Haemost; 2005 Aug; 3(8):1569-76. PubMed ID: 16102021
[TBL] [Abstract][Full Text] [Related]
77. Angiotensin, inflammation, hypertension, and cardiovascular disease.
Luft FC
Curr Hypertens Rep; 2001 Feb; 3(1):61-7. PubMed ID: 11177710
[TBL] [Abstract][Full Text] [Related]
78. Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury.
Li XC; Zhuo JL
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):37-43. PubMed ID: 18090668
[TBL] [Abstract][Full Text] [Related]
79. Workshop: mechanisms and cardiovascular damage in hypertension.
Luft FC
Hypertension; 2001 Feb; 37(2 Pt 2):594-8. PubMed ID: 11230340
[TBL] [Abstract][Full Text] [Related]
80. Modulation of angiotensin II-mediated signalling by heparan sulphate glycosaminoglycans.
Köppel H; Yard BA; Christ M; Wehling M; van der Woude FJ
Nephrol Dial Transplant; 2003 Nov; 18(11):2240-7. PubMed ID: 14551349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
